{"id":"W2968760378","doi":"10.1177/2475530319867095","title":"Ixekizumab—An Effective and Safe Treatment for Moderate-to-Severe Plaque Psoriasis in Patients Previously Treated With Other IL-17 Inhibitors: Results From IXORA-P","year":2019,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Secukinumab; Plaque psoriasis; Psoriasis; Internal medicine; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004795522,0.0005491029,0.001237042,0.0003397076,0.0001895455,0.00008652465,0.0001533091,0.0003805703,0.00009773039],"category_scores_gemma":[0.0001174263,0.0003991832,0.0001750063,0.0002052482,0.00007453166,0.0004199973,0.00003616533,0.0001864903,0.00002804676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002025722,"about_ca_system_score_gemma":0.0000986171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007512447,"about_ca_topic_score_gemma":0.0008511133,"domain_scores_codex":[0.9971917,0.0004579846,0.001020396,0.0006588892,0.0001413894,0.0005296663],"domain_scores_gemma":[0.9978687,0.0006880772,0.0006507601,0.0003520325,0.0002641683,0.0001762655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05055529,0.001813279,0.05378896,0.00004541022,0.002560303,0.00003410974,0.009556397,0.0001792401,0.0009597837,0.00009226473,0.001217403,0.8791975],"study_design_scores_gemma":[0.3867499,0.07590477,0.4494081,0.003706865,0.002990881,0.0002819125,0.002981894,0.0001232633,0.02851916,0.001531338,0.04482148,0.002980415],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930628,0.002514242,0.00005156327,0.0001459273,0.0009329546,0.001997008,0.001111887,0.00002204103,0.0001615698],"genre_scores_gemma":[0.9961863,0.001340831,0.001191975,0.00008739697,0.0003807879,0.0001452497,0.0002129094,0.00006229086,0.0003923144],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8762171,"threshold_uncertainty_score":0.999846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008997813675163136,"score_gpt":0.2217314020076513,"score_spread":0.2127335883324881,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}